Sufficient supplies of the Imvanex vaccine against monkeypox are available to handle the current outbreak, the producer of the shot told dpa on Wednesday. Bavarian Nordic is the only company in the world whose monkeypox vaccine has regulatory approval. It is currently possible to produce 30 million doses annually, spokesman Rolf Sass Sørensen said. Cases of monkeypox are spreading. The virus usually causes mild symptoms such as rash, fever and pustules, but can also be severe. The company is based in Denmark and produces the vaccine there, although it was initially developed in the German bran…